The HIT Network for Children and Adolescents With CNS Tumors Facilitates Improvements of Diagnostic Assessments, Multimodal Treatments, Individual Counseling, and Research in Germany, Austria, and Switzerland
Pediatric Blood & Cancer · 2026-05 · 73 (5)
DOI: 10.1002/1545-5017.70165 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pediatric Blood & Cancer, online erschienen am 16.03.2026. Verfasst von Stefan Rutkowski und 59 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatric Hematology and Oncology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. Hauptthemen laut MEDLINE: Central Nervous System Neoplasms, Counseling. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 75 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: German Children's Cancer Foundation, Bonn (Deutsche Kinderkrebsstiftung, Bonn).
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Background
The HIT network was established in 2000 to create a population‐based structure aiming to improve survival rates and reduce late effects for children with central nervous system (CNS) tumors by conducting comprehensive clinical trials.
Methods
The HIT network currently consists of 10 coordinating trial centers mandated by the German Society for Pediatric Oncology and Hematology (GPOH) to conduct clinical trials and research projects, and to provide counseling to local centers for individual patients. The network is complemented by 11 reference centers (neuropathology, tumor biology, neuroradiology, pediatric neurosurgery, cerebrospinal fluid [CSF], assessments, radiotherapy, genetics), biostatistical support, and currently 72 local treatment sites.
Results
Numbers of children and adolescents with newly diagnosed CNS tumors registered to trials and registries increased from approximately 500 to more than 600 per year, corresponding to >95% of affected HIT‐eligible children and adolescents in Germany. Clinical counseling and upfront reference assessments ensure homogeneous clinical standards and avoid inadequate treatment of individual patients. Since 2007, the established reference services have been partially re‐funded by German health insurances.
Discussion
The HIT network provides a unique structure for population‐based state‐of‐the‐art diagnostic assessments, treatment recommendations and counseling. It increases the “a priori” accuracy of stratification parameters, and the timely inclusion into clinical trials and tumor‐specific registries. Favorable outcomes are achieved within the trials and registry landscape, for example, through consistent reference assessments, reducing the gap to real world data. Resulting data facilitate representative, unbiased high‐quality research projects across all CNS tumor entities. Interdisciplinary cooperation and competitive scientific output are enhanced.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pediatric Hematology and Oncology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
- Pediatrics and Adolescent Medicine, Swabian Children's Cancer Center, Bavarian Cancer Research Center (BZKF) and KIONET, University Hospital Augsburg, Augsburg, Germany.
- Pediatrics III, University Hospital Essen, Essen, Germany.
- Department of Pediatric Oncology and Hematology, German HIT-LOGGIC-Registry For Low Grade Glioma in Children and Adolescents, CNS-InterREST Registry For Rare Embryonal and Sarcomatous tumors, Augustenburger Platz 1, Cha…
- National Center for Tumor Diseases (NCT), NCT Heidelberg, a Partnership Between DKFZ and Heidelberg University Hospital, Heidelberg, Germany.
- German Cancer Research Center (DKFZ), Heidelberg, Germany.
Förderung
- German Children's Cancer Foundation, Bonn (Deutsche Kinderkrebsstiftung, Bonn)
Zitieren
APA
Rutkowski, S., Frühwald, M. C., Fleischhack, G., Tippelt, S., Hernáiz-Driever, P., Witt, O., Gnekow, A., Kramm, C., Eyrich, M., Wolf, J. E. A., Müller, H., Friedrich, C., Kordes, U. R., Obrecht-Sturm, D., Ketteler, P., von Zezschwitz, B., Johann, P., Sturm, D., Nemes, K., …, & Mynarek, M. (2026). The HIT Network for Children and Adolescents With CNS Tumors Facilitates Improvements of Diagnostic Assessments, Multimodal Treatments, Individual Counseling, and Research in Germany, Austria, and Switzerland. Pediatric Blood & Cancer, 73(5). https://doi.org/10.1002/1545-5017.70165
Vancouver
Rutkowski S, Frühwald MC, Fleischhack G, Tippelt S, Hernáiz-Driever P, Witt O, et al. The HIT Network for Children and Adolescents With CNS Tumors Facilitates Improvements of Diagnostic Assessments, Multimodal Treatments, Individual Counseling, and Research in Germany, Austria, and Switzerland. Pediatric Blood & Cancer. 2026;73(5). doi:10.1002/1545-5017.70165
BibTeX
@article{Rutkowski2026,
author = {Rutkowski, Stefan and Frühwald, Michael C and Fleischhack, Gudrun and Tippelt, Stephan and Hernáiz-Driever, Pablo and Witt, Olaf and Gnekow, Astrid and Kramm, Christof and Eyrich, Matthias and Wolf, Johannes E A and Müller, Hermann and Friedrich, Carsten and Kordes, Uwe R and Obrecht-Sturm, Denise and Ketteler, Petra and von Zezschwitz, Barbara and Johann, Pascal and Sturm, Dominik and Nemes, Karoline and Schönberger, Stefan and Milde, Till and Bison, Brigitte and Warmuth-Metz, Monika and Pietsch, Torsten and Schüller, Ulrich and Koch, Arend and Capper, David and Hasselblatt, Martin and Thomas, Christian and Hagel, Christian and Pfister, Stefan M and Sahm, Felix and Jones, David T W and Schuhmann, Martin U and Krauss, Jürgen and Emami, Pedram and El Damaty, Ahmed and Kortmann, Rolf D and Schwarz, Rudolf and Debus, Jürgen and Krause, Mechthild and Pohl, Fabian and Ottensmeier, Holger and Bußenius, Lisa and Baust, Katja and Faldum, Andreas and Ronckers, Cecile and Grabow, Desiree and Benesch, Martin and Perwein, Thomas and Dieckmann, Karin and Slavc, Irene and Gojo, Johannes and Gerber, Nicolas U and von Bueren, André O and Scheinemann, Katrin and Calaminus, Gabriele and Timmermann, Beate and Thomale, Ulrich-Wilhelm and Mynarek, Martin},
title = {The HIT Network for Children and Adolescents With CNS Tumors Facilitates Improvements of Diagnostic Assessments, Multimodal Treatments, Individual Counseling, and Research in Germany, Austria, and Switzerland},
journal = {Pediatric Blood & Cancer},
year = {2026},
volume = {73},
number = {5},
doi = {10.1002/1545-5017.70165}
}
EUVIMED